Abstract
Our understanding of the intermediary events that occur between the reception of a biological signal at the cell membrane, and the eventual conversion of that signal to a change in gene expression at the nuclear level (i.e. signal transduction), has grown immensely over the last decade. Elucidation of signal transduction pathways in lung parenchymal cells and alveolar macrophages holds the promise of not only understanding the molecular mechanisms that contribute to acute lung injury (ALI), but also of providing novel therapeutic targets. Protein phosphorylation is the key regulatory mechanism in these pathways and the human genome has been estimated to encode more than one thousand protein kinases. An exhaustive review of the many signal transduction pathways in the lung is beyond the scope of this single chapter. Accordingly, we have focused this chapter on two pathways believed to be particularly relevant to the pathophysiology of ALI: the nuclear factor-κb (NF-kB) pathway and the activator protein-1 (AP-1) pathway.
Chapter PDF
Similar content being viewed by others
Keywords
- Acute Lung Injury
- Alveolar Macrophage
- Secretory Leukocyte Protease Inhibitor
- Human Respiratory Epithelium
- Pyridinyl Imidazole
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Baldwin, A. S. (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14, 649–681
Blackwell, T. S., and Christman, J. W. (1997) The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 17, 3–9
Ghosh, S., May, M. J., and Koop, E. B. (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16, 225–260
Abraham, E. (2000) NF-kappaB activation. Crit Care Med 28, (Suppl) N100–104
Wong, H. R., Ryan, M., and Wispé, J. R. (1997) The heat shock response inhibits inducible nitric oxide synthase gene expression by blocking Iκ-B degradation and NF-κB nuclear translocation. Biochem Biophys Res Comm 231, 257–263
Wong, H. R., Ryan, M., and Wispé, J. R. (1997) Stress response decreases NF-κB nuclear translocation and increases I-κBα and expression in A549 cells. J Clin Invest 99, 2423–2428
Mazor, R. L., Menendez, I. Y., Ryan, M. A., Fiedler, M. A., and Wong, H. R. (2000) Sesquiterpene lactones are potent inhibitors of interleukin-8 gene expression in cultured human respiratory epithelium. Cytokine 12, 239–245
Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Bauerle, P. A., and Peyron, J. F. (1996) Tryosine phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκBα. Cell 86, 787–798
Beraud, C., Henzel, W. J., and Baeuerle, P. A. (1999) Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation. Proc Natl Acad Sci 96, 429–434
Bender, K., Gottlicher, M., Whiteside, S., Rahmsdorf, H. J., and Herrlich, P. (1998) Sequential DNA damage-independent and -dependent activation of NF-κB by UV. EMBO J, 17 5170–5181
Ito, C. Y., Kazantsev, A. G., and Baldwin, A. S. (1994) Three NF-κB sites in the IκB-α: promoter are required for induction of gene expression by TNFα. Nucleic Acids Res 22, 3787–3792
Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M. S., Bachelerie, F., Thomas, D., and Hay, R. T. (1995) Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol 15, 2689–2696
Thompson, J. E., Phillips, R. J., Erdjument-Bromage, H., Tempst, P., and Ghosh, S. (1995) IκBß regulates the persistent response in a biphasic activation of NF-κB. Cell 80, 573–582
Karin, M., and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquiti-nation: the control of NF-κB activity. Annu Rev Immunol 18, 621–663
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548–554
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M., and Mann, M. (1997) IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860–866
Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., and Akira, S. (1999) Limb and skin abnormalities in mice lacking IKKα. Science 284, 313–316
Li, Q., Antwerp, D. V., Mercurio, F., Lee, K. F., and Verma, I. M. (1999) Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284, 321–325
Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284, 316–320
Li, Z. W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. (1999) The IKKß subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J Exp Med 189, 1839–1845
Ware, L., and Mathhay, M. (2000) The acute respiratory distress syndrome. N Engl J Med 342, 1334–1249
Shanley, T. P. (1998) Cytokines in inflammatory diseases: Role and therapeutic targets in acute respiratory distress syndrome. Emerging Therapeutic Targets 2, 1–16
Schutte, H., Lohmeyer, J., Rosseau, S., Ziegler, S., Siebert, C, Kielisch, H., Pralle, H., Grimminger, F., Morr, H., and Seeger, W. (1996) Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 9, 1858–1867
Miller, E. J., Cohen, A. B., Nagao, S., Griffith, D., Maunder, R. J., Martin, T. R., Weiner-Kronish, J. P., Sticherling, M., Christophers, E., and Matthay, M. A. (1992) Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 146, 427–432
Donnely, S. C, Strieter, R. M., Kunkel, S. M., Walz, A., Robertson, C. R., Carter, D. C., Grant, I. S., Pollock, A. J., and Haslett, C. (1993) Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341, 643–647
Mukaida, N., Okamoto, S., Ishikawa, Y., and Matsushima, K. (1994) Molecular mechanisms of interleukin-8 gene expression. J Leukoc Biol 56, 554–558
Allen, G. A., Menendez, I., Ryan, M., Mazor, R., Wispé, J., Fiedler, M., and Wong, H. R. (2000) Hyperoxia synergistically increases TNF-α-induced interleukin-8 gene expression in A549 cells. Am J Physiol 278, L253–L260
Blackwell, T. S., Yull, F. E., Chen, C. L., Venkatakrishnan, A., Blackwell, T. R., Hicks, D. J., Lancaster, L. H., Christman, J. W., and Kerr, L. D. (2000) Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med 162, 1095–1101
Amory-Rivier, C. F., Mohler, J., Bedos, J. P., Azoulay-Dupuis, E., Henin, D., Muffat-Joly, M., Carbon, C., and Moine, P. (2000) Nuclear factor-kappaB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection. Crit Care Med 28, 3249–3256
Blackwell, T. S., Lancaster, L. H., Blackwell, T. R., Venkatakrishnan, A., and Christman, J. W. (1999) Differential NF-kappaB activation after intra-tracheal endotoxin. Am J Physiology 277, L823–L830
Lentsch, A. B., Jordan, J. A., Czermak, B. J., Diehl, K. M., Younkin, E. M., Sarma, V., and Ward, P. A. (1999) Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol 154, 239–247
Lentsch, A. B., Czermak, B. J., Jordan, J. A., and Ward, P. A. (1999) Regulation of acute lung inflammatory injury by endogenous IL-13. J Immunol 162, 1071–1076
Moine, P., Shenkar, R., Kaneko, D., Tulzo, Y. L., and Abraham, E. (1997) Systemic blood loss affects NF-kappa B regulatory mechanisms in the lungs. Am J Physiol 273, L185–L192
Shenkar, R., and Abraham, E. (1999) Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 163, 954–962
Yoshidome, H., Kato, A., Edwards, M. J., and Lentsch, A. B. (1999) Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion. Am J Physiol 277, L919–923
Lentsch, A. B., Czermak, B. J., Bless, N. M., Rooijen, N. V., and Ward, P. A. (1999) Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. Am J Respir Cell Mol Biol 20, 692–698
Ross, S. D., Kron, I. L., Gangemi, J. J., Shockey, K. S., Stoler, M., Kern, J. A., Tribble, C. G., and Laubach, V. E. (2000) Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-kappaB. Am J Physiol 279, L528–L536
Schwartz, M. D., Moore, E. E., Moore, F. A., Shenkar, R., Moine, P., Haenel, J. B., and Abraham, E. (1996) Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 24, 1285–1292
Moine, P., McIntyre, R., Schwartz, M. D., Kaneko, D., Shenkar, R., Le Tulzo, Y., Moore, E. E., and Abraham, E. NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. (2000) Shock 13, 85–91
Bohrer, H., Qiu, F., Zimmerman, T., Zhang, Y., Jllmer, T., Mannel, D., Bottiger, B. W., Stern, D., Waldherr, R., Saeger, H.-D., Ziegler, R., Bierhaus, A., Martin, E., and Nawtroth, P. P. (1997) Role of NF-κB in the mortality of sepsis. J Clin Invest 100, 972–985
Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270, 16483–16486
Karin, M., Liu, Z., and Zandi, E. (1997) AP-1 function and regulation. Curr Opin Cell Biol 9, 240–246
Angel, P., and Karin, M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072, 129–157
Hai, T., and Curran, T. (1991) Cross-family dimerization of transcription factors fos/jun and ATF/CREB alters DNA-binding specificity. Proc Natl Acad Sci USA 88, 3720–3724
Ziff, E. B. (1990) Transcription factors: a new family gathers at the cAMP response site. Trends Genet 6, 69–72
Davis, R. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239–252
Herlaar, E. and Brown, Z. (1999) p38 MAPK signaling cascade in inflammatory disease. Mol Med Today 5, 439–447
Ip, Y. T., and Davis, R. J. (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10, 205–219
Su, B., and Karin, M. (1996) Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8, 402–411
Garrington, T. P., and Johnson, G. L. (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11, 211–218
Keyse, S. M. (1998) Protein phosphatases and the regulation of MAP kinase activity. Semin Cell Dev Biol 9, 143–152
Read, M. A., (1997) Tumor necrosis factor a-induced E-selectin expression is activated by the nuclear factor-κB and c-jun N-terminal kinase/p38 mitogen-kinase activated protein kinase pathways. J Biol Chem. 272, 2753–2761
Nick, J. A., Avdi N. J., Young, S. K., Lehman, L. A., McDonald, P. P., Frasch, S. C., Billstrom, M. A., Henson, P. M., Johnson, G. L., and Worthen, G. S. (1999) Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 103, 851–858
Bauer, G. J., Garcia, I. and Maier, R. V. (1997) Activation of stress-activated protein kinase is a mechanism of priming in macrophages. Surg Forum 48, 43–45
Ridley, S. H. (1997) Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase. Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 158, 3165–3173
Jorres, R. A. and Magnussen, H. (1997) Oxidative stress in COPD. Eur Respir Rev. 7, 131–135
Patrick, D. A. (1997) Role of p38 MAP kinase in human neutrophil priming for superoxide production and elastase release. Surg Forum 48, 48–50
Badger, A. M., Bradbeer, J. N., Votta, B., Lee, J. C., Adams, J. L., and Griswold, D. E. (1996) Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279, 1453–1461
Carter, A. B., Monick, M. M., and Hunninghake, G. W. (1999) Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 20, 751–758
Nick, J. A., Young, S. K., Brown, K. K., Avdi N. J., Arndt, P. G., Suratt, B. T., Janes, M. S., Henson, P. M., and Worthen, G. S. (2000) Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol 164, 2151–2159
Underwood, D.C., Osborn, R. R., Kotzer, C. J., Adam, J. L., Lee, J. C., Webb, E. F., Carpenter, D. C., Bochnowicz, S., Thomas, H. C., Hay, D. W., and Griswold, D. E. (2000) SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther 293, 218–288
Jackson, J. R., Bolognese, B., Hillegass, L., Kassis, S., Adams, J., Griswold, D. E., and Winkler, J. D. (1998) Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther 284:687–692, 1998
Niiro, H., Otsuka, T., Ogami, E., Yamaoka, K., Nagano, S., Akahoshi, M., Nakashima, H., Arinobu, Y., Izuhara, K., and Niho, Y. (1998) MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem Biophys Res Commun 250, 200–205
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A. and Davis, R. J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870–874
Yujiri, T., Sather, S., Fanger, G. R., and Johnson, G. L. (1998) Role of MEKK-1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science 282, 1911–1914
Baud, V., Liu, Z.-G., Bennett, B., Suzuki, N., Xia, Y., and Karin, M. (1999) Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Develop 13, 1297–1308
Han, J., Huez, G., and Beutler, B. (1991) Interactive effects of the TNF promoter and 3′-untranslated regions. J Immunol 146, 1843–1848
Swantek, J. L., Cobb, M. H., and Geppert, T. D. (1997) Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: Glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol Cell Biol 17, 6274–6282
Shanley, T. P., Vasi, N., Deneberg, A., and Wong, H. R. (2001) The serine/threonine phosphatase, PP2A: Endogenous regulator of inflammatory cell signaling. J Immunol 166, 966–972
Hambleton, J., Weinstein, S. L., Lern, L., and DeFranco, A. L. (1996) Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 93, 2774–2778
Burack, W. R., and Shaw, A. S. (2000) Signal transduction: hanging of a scaffold. Curr Opin Cell Biol 12, 211–215
Chen, W., Monick, M. M., Carter, A. B., and Hunninghake, G. W. (2000) Activation of ERK2 by respiratory syncytial virus in A549 cells is linked to the production of interleukin-8. Exp Lung Res 26, 13–26
Procyk, K. J., Kovarik, P., von Gabain, A., and Baccarini, M. (1999) Salmonella typhimurium and lipopolysaccharide stimulate extracellularly regulated kinase activation in macrophages by a mechanism involving phosphatidylinositol 3-kinase and phospholipase D as novel intermediates. Infect Immun 67, 1011–1018
Meyer, C. F., Wang, X., Chang, C., Templeton, D., and Tan, T. H. (1996) Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase-1 signaling cascade in mediating kappaB enhancer activation. J Biol Chem 271, 8971–8976
Janssen-Heininger, Y. M., Macara, I., and Mossman, B. T. (1999) Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am J Respir Cell Mol Biol 20, 942–952
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shanley, T.P., Wong, H.R. (2001). Signal Transduction Pathways in Acute Lung Injury: Nf-κB and Ap-1. In: Wong, H.R., Shanley, T.P. (eds) Molecular Biology of Acute Lung Injury. Molecular and Cellular Biology of Critical Care Medicine, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1427-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1427-5_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5548-9
Online ISBN: 978-1-4615-1427-5
eBook Packages: Springer Book Archive